Top Markets
#1 Official Trump Official Trump +36.17%
#2 Siacoin Siacoin +22.83%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +19.38%
#4 Melania Meme Melania Meme +19.00%
#5 Pump.fun Pump.fun +18.96%
#6 Unit Pump Unit Pump +18.96%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.45%
#9 Mubarak Mubarak +17.59%
#10 POL (ex-MATIC) POL (ex-MATIC) +16.45%
Coin of the day
Official Trump Official Trump
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Rang in Aktien #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Aktienkurs
$1.81
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$77.00M
Veränderung (1 Tag)
1.30%
Veränderung (1 Jahr)
-23.63%
Land
US
Handel Annovis Bio, Inc. (ANVS)

Kategorie

Healthcare
Kursverlauf für Annovis Bio, Inc. (ANVS)
Höchster Schlusskurs: $1.82 am 2026-08-01

Niedrigster Schlusskurs: $7.71 am 2020-01-01
Kursverlauf der Aktie von Annovis Bio, Inc. von 2020 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH